Cleerly LABS vs Viz RV/LV
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary goal is a comprehensive, detailed assessment of coronary atherosclerosis and stenosis for personalized long-term heart disease management. This tool is ideal for quantifying plaque volume and type, tracking disease progression over time, and refining risk stratification beyond traditional methods.
View Cleerly LABS →Choose Viz RV/LV if…
Choose Viz RV/LV if you require rapid, automated right and left ventricular diameter measurements from CTPA scans to quickly stratify pulmonary embolism risk in acute settings. This tool is best suited for emergency medicine and pulmonology workflows where timely identification of RV strain is critical for guiding immediate patient management and coordinating care teams efficiently.
View Viz RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Viz RV/LV |
|---|---|---|
| Pricing | Varies | Unknown |
| Deployment | Cloud, On-premise | Cloud-based |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVViz RV/LV emphasizes rapid, automated alerts, mobile access via a high-fidelity DICOM viewer, and an integrated communication platform for care coordination. This approach offers immediate and widespread usability for a larger care team in time-sensitive, acute settings, streamlining critical workflows.
Clinical Value
Cleerly LABSCleerly LABS provides comprehensive, quantitative, and longitudinal assessment of coronary plaque, including volume, type, stenosis, and ischemia detection, aiding in personalized heart disease management and tracking progression over time. This offers a broader, long-term clinical impact for a widespread chronic condition compared to Viz RV/LV's acute risk stratification for pulmonary embolism.
Pricing & Value
Cleerly LABSCleerly LABS offers transparent pricing per analysis, allowing potential users to clearly evaluate its cost-effectiveness. In contrast, Viz RV/LV does not publicly disclose its pricing, making it impossible to assess its value proposition without further inquiry.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, featuring FDA clearance, HIPAA compliance, BAA availability, and cloud-based deployments. Cleerly LABS integrates with PACS, RIS, and EHR via a proxy, while Viz RV/LV is a seamless component of the Viz PE Solution with a HIPAA-compliant communication platform, indicating robust integration within their respective operational ecosystems.
Innovation
Cleerly LABSCleerly LABS represents a significant innovation by providing a comprehensive, quantitative, and longitudinal assessment of coronary plaque, moving beyond traditional stenosis-focused evaluation. This approach aims to create a new standard of care for personalized heart disease management and prevention, which is a more fundamental shift in diagnostic paradigm.
Support & Docs
Viz RV/LVViz.ai offers 24/7/365 urgent phone support and provides dedicated customer success teams, including clinical and workflow specialists, along with a comprehensive help center and Viz Academy. Cleerly provides support during business hours and various resources, but lacks the immediate, round-the-clock availability and specialized customer success structure of Viz.ai.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Viz RV/LV |
|---|---|---|
| Tool Name | Cleerly LABS | Viz RV/LV |
| Primary Use Case | Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | Automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination. |
| Company | Cleerly | Viz.ai |
| Primary Imaging Modality | Coronary CT Angiography (CCTA) | CTPA scans |
| Core AI Functionality | AI-powered CCTA image analysis for comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification. | AI algorithm for identification and measurement of heart ventricles to provide automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement. |
| Integration/Ecosystem | Integration with PACS, RIS, EHR via Cleerly Proxy. | Seamless component of the Viz PE Solution; HIPAA-compliant communication platform for care coordination. |
| Specialties | Cardiology, Radiology | Emergency Medicine, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Viz RV/LV.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Viz RV/LV
Backers
Who funded each tool's parent company.